Chemocentryx reported $933.95M in Market Capitalization for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Abbvie ABBV:US $ 198.95B 7.96B
Alexion Pharmaceuticals ALXN:US $ 33.78B 393.15M
Alnylam Pharmaceuticals ALNY:US $ 19.93B 3.36B
Amgen AMGN:US $ 140.05B 3.22B
AstraZeneca AZN:LN 113.99B 18.86B
Bayer BAYN:GR 50.48B 2.53B
Biogen BIIB:US $ 52.13B 9.52B
Biomarin Pharmaceutical BMRN:US $ 15.25B 1.45B
Bristol Myers Squibb BMY:US $ 148.48B 7.52B
Chemocentryx CCXI:US $ 933.95M 2.64B
GlaxoSmithKline GSK:LN 71.42B 6.62B
Glaxosmithkline GSK:US 98.75B 9.46B
Johnson & Johnson JNJ:US $ 425145.86M 8679.8M
Macrogenics MGNX:US $ 1.62B 176.65M
Merk MRK:US $ 196918.18M 1780.24M
Mirati Therapeutics MRTX:US $ 8.31B 483.81M
Novartis NOVN:VX 208.02B 8.76B
Omeros OMER:US $ 924.95M 177.47M
Pfizer PFE:US $ 219205.69M 17108.81M
Sanofi SAN:FP 111.4B 5.33B
Sarepta Therapeutics SRPT:US $ 6.2B 282.45M
Takeda 4502:JP 5869.99B 411.92B
Teva Pharmaceutical TEVA:IT 35.79B 6.09B
UCB UCB:BB 17.15B 715.78M
YTE INCY:US $ 18.5B 632.77M